Michael Sierra, PhD in chemistry, is an accomplished executive with extensive experience in drug discovery and technology development. He has built and led high-performing teams in R&D within large and midsize pharmaceutical companies as well as biotech. Sierra is known for de-risking disruptive technologies by leveraging external innovation models and leading successful cross-functional drug discovery teams, making him a change agent who continually pushes the edge in terms of organizational and cultural transformation of the organization. His core competencies include Product Innovation, Global Research Networks, Drug Discovery, Novel R&D Business Models, Scientific and Strategic Leadership, New Technologies, Empower Others, Budget Accountability, Cross-Functional Collaboration, Team Leadership, and Visionary. Sierra has been a member of R&D Senior Leadership Teams, Scientific Review, Joint Steering Committees, Advisory and Discovery Portfolio & Prioritization Boards.

Sierra's education background includes a Leadership Program from IMD (International Institute for Management Development) for Business Programs, Postdoc in Chemistry from Ecole Polytechnique, PhD in Chemistry from Wayne State University, and Bachelor of Science (BSc) in Chemistry from Ohio Northern University. He's a former steering committee member at Skin Science Foundation, member of Steering Committee - Advancing the Field of Dermatology at Advancing Innovation in Dermatology, Inc., Innovation Judge and Mentor at Hacking Dermatology, member of Funding Board - Sandbox Innovation Fund Program at MIT Sandbox Innovation Fund Program Vice President at LEO Science & Tech Hub, Executive Director of Translational Research at LEO Pharma A/S, Director of External Discovery (EDisc) at LEO Pharma A/S, Director of Chemical Research at LEO Pharma A/S, Director of Medicinal Chemistry at LEO Pharma A/S, Director of Chemistry at CareX, and Expert Scientist at GlaxoSmithKline.